DREAM: an adaptive, randomised, placebo-controlled trial of duloxetine for reducing leg pain in people with chronic sciatica—trial protocolHanan McLachlan, Christopher G Maher, Chung-Wei Christine Lin, Laurent Billot, Richard O Day, Rowena Ivers, Martin Underwood, Andrew J McLachlan, Bethan Richards, Nanna B Finnerup, Giovanni E Ferreira, , on behalf of the DREAM Study Group, Giovanni E Ferreira, Christopher G MaherSee the full list of authors
31 December 2024
Quantitative evaluation of GPT-4’s performance on US and Chinese osteoarthritis treatment guideline interpretation and orthopaedic case consultationJuntan Li, Xiang Gao, Tianxu Dou, Yuyang Gao, Xu Li, Wannan Zhu
30 December 2024
Association between maternal systemic lupus erythematosus and infant infection: a population-based cohort study in SwedenSofie A M Gernaat, Julia F Simard, Maria Altman, Elisabet Svenungsson, Elizabeth V Arkema
23 December 2024
Protocol for a multicentre randomised triple-blind controlled trial assessing the clinical efficacy of intra-articular platelet-rich plasma injections versus placebo in symptomatic knee osteoarthritis (PIKOA)Florent Eymard, Nadia Oubaya, Paul Ornetti, Jeremie Sellam, Pascal Richette, Xavier Chevalier, , PIKOA study group, Edem Allado, Olivier Brocq, Caroline Charpin, Xavier Chevalier, Thierry Conrozier, Grégoire Cormier, Florent EymardSee the full list of authors
29 November 2024
Knowledge, attitude and practice of urticaria patients towards urticaria medication treatment: a cross-sectional study at the first affiliated hospital of Kunming Medical UniversityYan Shen, Weijia Zhao
27 November 2024
Testing the efficacy of WORK-ON: vocational rehabilitation for people with chronic inflammatory arthritis in Denmark—protocol for a randomised controlled trialChristina Merete Tvede Madsen, Jette Primdahl, Jeanette Reffstrup Christensen
27 November 2024
Becoming Active in Beating osteoarthritiS: study protocol of a randomised controlled trial on the effectiveness of an information campaign in improving the management of osteoarthritis and quality of care in general practices in the NetherlandsJeanne Oomen, Henk Schers, Enny Das, Sander Koeter, Cornelia HM van den Ende, Willem JJ Assendelft
20 November 2024
Optimal timing of recombinant herpes zoster virus vaccination for a JAK inhibitor treatment in rheumatoid arthritis: a multicentre, open-label, randomised comparative study (STOP-HZ study): study protocolSatoshi Takanashi, Koichiro Ohmura, Kenta Misaki, Atsushi Ihata, Toshihiro Matsui, Shigeto Tohma, Jun Saegusa, Shinji Sato, Tsukasa Matsubara, Kunihiro Yamaoka, Koichi Amano, Toshiaki Miyamoto, Yasuko Mori, Yuko Kaneko
17 November 2024
Immunogenicity of adalimumab reference product and adalimumab-adbm in patients with rheumatoid arthritis, Crohn’s disease and chronic plaque psoriasis: a pooled analysis of the VOLTAIRE trialsVibeke Strand, Dorothy McCabe, Shaun Bender
17 November 2024
Prevalence of comorbidities among patients with rheumatoid arthritis in the UAE: a case–control studyJamal Al-Saleh, Naureen Ali Khan, Noura Zamani, Hend AlSaidi, Wafae Rachidi
12 November 2024
